Physician profile
Robert Allan Lizer
NPI 1184624280
$994.47
in general payments reported to CMS, 2019-2025
20 companies · $46.24 in 2025
The $46.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $135 · 2021: $92.82 · 2022: $116 · 2023: $145 · 2025: $46.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.64 | 2019-2023 | Farxiga |
| Alkermes, INC. | $95.70 | 2022-2025 | Vivitrol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $80.25 | 2019 | |
| Abbott Laboratories | $79.34 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $57.37 | 2019-2020 | |
| Amgen INC. | $56.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $54.32 | 2020-2023 | |
| Lilly USA, LLC | $43.89 | 2019-2020 | |
| Indivior INC. | $35.95 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $35.74 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $33.14 | 2021 | |
| Astellas Pharma US INC | $30.72 | 2019 | |
| Allergan, INC. | $29.99 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.97 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24.88 | 2019-2020 | |
| Sanofi Pasteur INC. | $22.05 | 2019 | |
| Gilead Sciences, INC. | $13.43 | 2019 | |
| Amarin Pharma, INC. | $12.92 | 2019 | |
| Novo Nordisk INC | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.